DK0443598T3 - Blodkoagulationsinhiberende peptider, fremgangsmåde til deres fremstilling samt deres anvendelse - Google Patents

Blodkoagulationsinhiberende peptider, fremgangsmåde til deres fremstilling samt deres anvendelse

Info

Publication number
DK0443598T3
DK0443598T3 DK91102607.8T DK91102607T DK0443598T3 DK 0443598 T3 DK0443598 T3 DK 0443598T3 DK 91102607 T DK91102607 T DK 91102607T DK 0443598 T3 DK0443598 T3 DK 0443598T3
Authority
DK
Denmark
Prior art keywords
glu
asp
atoms
phe
bond
Prior art date
Application number
DK91102607.8T
Other languages
English (en)
Inventor
Werner Dr Stueber
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Application granted granted Critical
Publication of DK0443598T3 publication Critical patent/DK0443598T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK91102607.8T 1990-02-22 1991-02-22 Blodkoagulationsinhiberende peptider, fremgangsmåde til deres fremstilling samt deres anvendelse DK0443598T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4005591A DE4005591A1 (de) 1990-02-22 1990-02-22 Die blutgerinnung inhibierende peptide, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
DK0443598T3 true DK0443598T3 (da) 1995-09-25

Family

ID=6400736

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91102607.8T DK0443598T3 (da) 1990-02-22 1991-02-22 Blodkoagulationsinhiberende peptider, fremgangsmåde til deres fremstilling samt deres anvendelse

Country Status (11)

Country Link
EP (1) EP0443598B1 (da)
JP (1) JPH0770181A (da)
KR (1) KR910021412A (da)
AT (1) ATE122684T1 (da)
AU (1) AU640739B2 (da)
CA (1) CA2036815A1 (da)
DE (2) DE4005591A1 (da)
DK (1) DK0443598T3 (da)
ES (1) ES2073601T3 (da)
IE (1) IE66493B1 (da)
PT (1) PT96836B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4103649A1 (de) * 1991-02-07 1992-08-13 Basf Ag Neue antikoagulatorisch wirksame peptide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341032C (en) * 1987-01-23 2000-06-20 John L. Krstenansky Anticoagulant peptides
CA2064231A1 (en) * 1989-07-20 1991-01-21 John M. Maraganore Combinations and methods for treating or preventing thrombotic diseases
AU6070490A (en) * 1989-08-07 1991-03-11 Motorola, Inc. Speech recognition using spectral line frequencies
US5196404B1 (en) * 1989-08-18 1996-09-10 Biogen Inc Inhibitors of thrombin

Also Published As

Publication number Publication date
PT96836A (pt) 1991-10-31
EP0443598A2 (de) 1991-08-28
EP0443598A3 (en) 1992-01-08
DE4005591A1 (de) 1991-09-05
JPH0770181A (ja) 1995-03-14
CA2036815A1 (en) 1991-08-23
IE66493B1 (en) 1996-01-10
EP0443598B1 (de) 1995-05-17
ES2073601T3 (es) 1995-08-16
IE910597A1 (en) 1991-08-28
DE59105479D1 (de) 1995-06-22
AU640739B2 (en) 1993-09-02
KR910021412A (ko) 1991-12-20
PT96836B (pt) 1998-07-31
ATE122684T1 (de) 1995-06-15
AU7125591A (en) 1991-08-29

Similar Documents

Publication Publication Date Title
ES2041611T1 (es) Un pentapeptido ciclico y su procedimiento de preparacion.
CA2050300A1 (en) Tnf-inhibiting proteins and the preparation thereof
DE68928810D1 (de) Analoge vom menschlichen Insulin
PT95661A (pt) Processo de preparacao de peptidos ciclicos e de composicoes farmaceuticas que os contem
KR900701843A (ko) 사람 Fcr 수용체 III
KR910007959A (ko) 방사성 동위원소로 표지된 항응고성 펩티드
Murata et al. Amino acid sequence of a basic blue protein from cucumber seedlings
Lemaire et al. Synthesis and biological activity of. beta.-endorphin and analogs. Additional evidence for multiple opiate receptors
ES2056753A6 (es) Un procedimiento para la produccion de un polipeptido que tiene actividad de factor quemotactico de monocitos humanos.
PT96836A (pt) Processo para a preparacao de peptideos inibidores da coagulacao sanguina
DK162130C (da) Grf-analoge peptider, fremgangsmaade til fremstilling deraf, grf-analoge peptider som terapeutiske midler, anvendelse af grf-analoge peptider, fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende grf-analoge peptider samt parenterale farmaceutiske praeparater indeholdende grf-analoge peptider
CA2026376A1 (en) Anticoagulant peptides
Bloemendal et al. Growing Insight into the Structure of β-crystallin: A Review
NZ334714A (en) Liver proteins as agents against autoimmune diseases
Huang et al. An antiplatelet peptide, gabonin, from Bitis gabonica snake venom
SE8603546D0 (sv) Polypeptider och framstellningsforfarande derav
EP0292257A3 (en) Peptides having anf activity
ATE84042T1 (de) Peptide.
ES2076933T3 (es) Nuevos sustratos peptidicos.
KR840000477A (ko) 헨테트 라콘타펩티드 crj 및 그 동족체와 관련된 펩티드류의 제조 방법
JP2023523899A (ja) ニコチン性アセチルコリン受容体活性を阻害するためのペプチド組成物および方法
SE7909653L (sv) Tyrosylerade proinsulin c-peptidderivat
ES437091A1 (es) Procedimiento para la fabricacion de peptidos.
Smith et al. Ultrastructural studies of the human complement components C3 and factor B and of cobra venom factor (CVF)
Monahan et al. Studies of the interaction of C8 and C9 within the membrane-bound cytolytic complex of complement